Cleveland Clinic Researchers Receive NIH Grant to Study Cancer-Associated Thrombosis

THE NATIONAL Heart, Lung, and Blood Institute has awarded a $4.7 million grant to the Cleveland Clinic to study the prevention of cancer-associated thrombosis. The 5-year grant supports the creation of a new risk assessment tool to better predict patients with cancer who have a higher probability of developing blood clots during treatment. The project, led by Keith McCrae, MD, and Alok Khorana, MD, of the Cleveland Clinic’s Taussig Cancer Institute and Lerner Research Institute, will incorporate data from more than 5,000 patients with colorectal, lung, and pancreatic cancers enrolled in clinical trials. ■